Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway.

Bueno MJ, Gómez de Cedrón M, Gómez-López G, Pérez de Castro I, Di Lisio L, Montes-Moreno S, Martínez N, Guerrero M, Sánchez-Martínez R, Santos J, Pisano DG, Piris MA, Fernández-Piqueras J, Malumbres M.

Blood. 2011 Jun 9;117(23):6255-66. doi: 10.1182/blood-2010-10-315432. Epub 2011 Apr 8.

2.

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR, Wirth T.

Blood. 2008 Nov 15;112(10):4202-12. doi: 10.1182/blood-2008-03-147645. Epub 2008 Aug 19.

3.

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.

Cancer Res. 2007 Oct 15;67(20):9762-70.

4.

Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.

Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L.

PLoS One. 2010 Sep 24;5(9). pii: e12960. doi: 10.1371/journal.pone.0012960.

5.

Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data.

Xiong L, Jiang W, Zhou R, Mao C, Guo Z.

Comput Biol Med. 2013 Sep;43(9):1252-60. doi: 10.1016/j.compbiomed.2013.06.002. Epub 2013 Jun 13.

PMID:
23930820
6.

ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.

Ben-Yosef T, Yanuka O, Benvenisty N.

Oncogene. 1996 Nov 7;13(9):1859-66.

PMID:
8934531
7.

MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M.

Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5.

8.

MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.

Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, Renner C, Grässer FA.

PLoS One. 2012;7(8):e42193. doi: 10.1371/journal.pone.0042193. Epub 2012 Aug 3.

9.

Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.

Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, Rehrauer H, Schlapbach R, Dirnhofer S, Tzankov A, Müller A.

Blood. 2011 Jun 9;117(23):6227-36. doi: 10.1182/blood-2010-10-312231. Epub 2011 Apr 1.

10.

MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.

Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, Leoncini L.

J Pathol. 2008 Dec;216(4):440-50. doi: 10.1002/path.2410.

PMID:
18802929
11.

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.

Ott G, Rosenwald A, Campo E.

Hematology Am Soc Hematol Educ Program. 2013;2013:575-83. doi: 10.1182/asheducation-2013.1.575. Review.

PMID:
24319234
12.

Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.

Seitz V, Butzhammer P, Hirsch B, Hecht J, Gütgemann I, Ehlers A, Lenze D, Oker E, Sommerfeld A, von der Wall E, König C, Zinser C, Spang R, Hummel M.

PLoS One. 2011;6(11):e26837. doi: 10.1371/journal.pone.0026837. Epub 2011 Nov 10.

13.

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Tao J, Zhao X, Tao J.

Cell Cycle. 2014;13(2):191-8. doi: 10.4161/cc.27646. Epub 2014 Jan 6. Review.

14.

MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.

Hother C, Rasmussen PK, Joshi T, Reker D, Ralfkiær U, Workman CT, Heegaard S, Ralfkiær E, Grønbæk K.

Invest Ophthalmol Vis Sci. 2013 Aug 5;54(8):5169-75. doi: 10.1167/iovs.13-12272.

PMID:
23821202
15.

Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

Smith-Sørensen B, Hijmans EM, Beijersbergen RL, Bernards R.

J Biol Chem. 1996 Mar 8;271(10):5513-8.

16.

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project..

Haematologica. 2014 Apr;99(4):726-35. doi: 10.3324/haematol.2013.091827. Epub 2013 Oct 31.

17.

A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8164-9. Epub 2003 Jun 13.

18.

Widespread microRNA repression by Myc contributes to tumorigenesis.

Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT.

Nat Genet. 2008 Jan;40(1):43-50. Epub 2007 Dec 9.

19.

Altered c-myc RNA metabolism in Burkitt's lymphomas and mouse plasmacytomas.

Piechaczyk M, Bonnieu A, Eick D, Remmers E, Yang JQ, Marcu K, Jeanteur P, Blanchard JM.

Curr Top Microbiol Immunol. 1986;132:331-8. No abstract available.

PMID:
3024921
20.

Myc suppression of Nfkb2 accelerates lymphomagenesis.

Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL.

BMC Cancer. 2010 Jul 2;10:348. doi: 10.1186/1471-2407-10-348.

Supplemental Content

Support Center